Ovid Therapeutics (OVID) Appoints Stelios Papadopoulos to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. OPCH
5. BBIO
6. NVDA
7. GOOGL
8. CHRW
9. AMD
10. STZ

Go back to Ovid Therapeutics (OVID) Appoints Stelios Papadopoulos to its Board

Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors

March 3, 2025 8:00 AM EST

NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small-molecule medicines for brain conditions with significant unmet need, today announced the appointment of Stelios Papadopoulos, Ph.D. to its Board of Directors.

Stelios is a pioneering force in biotechnology. His vision and strategic acumen have shaped the landscape of our industrybuilding companies, financing breakthroughs, and enabling transformative medicines. We are honored to welcome him to our Board at a defining moment for Ovid, said Jeremy Levin, D.Phil, MB BChir, Chairman... More